PA-based Burro secures $24M in series B round funding. The round was led by Catalyst Investors and Translink Capital with previous investors S2G Ventures,...
Palo Alto-based anecdotes secures $25M in series B round funding. Glilot Capital Partners led the round, which also included participation from Vertex and DTCP,...
Boston-based Nabla secures $24M in series B round funding. Zebox Ventures and Cathay Innovation led the $43 million round, which raised the total amount.
The...
Human Immunology Biosciences (HI-Bio™), a clinical-stage biotechnology company developing targeted therapies for patients with severe immune-mediated diseases (IMDs), announced the closing of a $95 million Series B financing led by new investor Alpha Wave Global. Viking Global Investors and Arkin Bio Capital participated in the financing, as well as existing investors Jeito Capital and ARCH Venture Partners.
To support rapid consumer adoption and expansion plans, Perplexity has raised $73.6 million in Series B funding from trusted VC firms and prominent tech visionaries. IVP led the round with continued support from Perplexity's Seed and Series A investors NEA, Elad Gil, Nat Friedman, and Databricks, as well as new investors NVIDIA, Jeff Bezos (through Bezos Expeditions Fund), Tobi Lutke, Bessemer Venture Partners, Naval Ravikant, Balaji Srinivasan, Guillermo Rauch, Austen Allred, Factorial Funds, and Kindred Ventures, among others.
CA-based clinical stage biotech company Lassen Therapeutics secures $85M in series B round funding. Frazier Life Sciences co-led the financing along with new investor...
IN-based Biopharmaceutical Company Sudo Biosciences Secures $116M in Series B Round Funding. The Company has raised a total of $157 million funding since its...
Emeryville-based Totus Medicines secures $66M series B round funding led by DCVC Bio. Neil Dhawan, Ph.D, Totus co-founder, founding CEO, and CSO, will transition...
Colorado-based True Anomaly secures $100 million in Series B Funding. Riot Ventures led the round, with participation from Champion Hill Ventures, Eclipse, ACME Capital, Menlo...
